已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Performance of Management Strategies With Class I Recommendations Among Patients Hospitalized With ST-Segment Elevation Myocardial Infarction in China

医学 仰角(弹道) 心肌梗塞 中国 内科学 ST段 急诊医学 心脏病学 几何学 政治学 数学 法学
作者
Yongchen Hao,Dong Zhao,Jing Liu,Jun Liu,Na Yang,Yong Huo,Gregg C. Fonarow,Junbo Ge,Louise Morgan,Changsheng Ma,Yaling Han,Sidney C. Smith,Mingcheng Bai,Bin Cui,Dongsheng Chai,Rong Chang,Jiyan Chen,Moshui Chen,Guoxiong Chen,Kaihong Chen,Kaiming Chen,Manhua Chen,Xiaoping Chen,Ximing Chen,Ping Chen,Xia Chen,Guoduo Chen,Jie Chen,Xiufeng Chen,Shengyong Chen,Yanyou Xie,Huimin Chu,Honghua Deng,Junping Deng,Jinglan Diao,Jiawang Ding,Pingshuan Dong,Hui Dong,Tianmin Du,Juexin Fan,Weiqing Fan,Junping Fang,Xiaoyun Feng,Guosheng Fu,Xianghua Fu,Fudong Gan,Chuanyu Gao,Junbo Ge,Jun Guan,Ying Guo,Yansong Guo,Haiping Guo,Guangshu Han,Minghua Han,Yaling Han,Yinglu Hao,Shenghu He,Zhaofa He,Zeyuan He,Yuqing Hou,Ping Hou,Jing Hu,Lan Huang,Weijian Huang,Yixiang Huang,Fangfang Huang,Yuehua Huang,Zhenguo Ji,Ji Lang,Zheng Ji,Shaobin Jia,Nan Jia,Jie Jiang,Li Jiang,Weihong Jiang,Hong Jiang,Yuan Jin,Chunlin Lai,Meisheng Lai,Bao Li,Bin Li,Guoqing Li,Hongwei Li,Jianhao Li,Junxia Li,Lang Li,Ling Li,Tianchang Li,Yongdong Li,Aihua Li,Jifu Li,Shuangbin Li,Xue Li,Zhanquan Li,Yong Li,Xiaolei Li,Dongyan Li,Songbai Li,Guo Li,Yue Li,Xudong Li,Wei Wang,Xiaolan Li,Naiyi Liang,Chuanliang Liang,Wenhua Lin,Yingzhong Lin,Hailong Lin,Rong Lin,Haiyun Lin,Bin Liu,Jun‐Ming Liu,Xiaohui Liu,Wei Jun Liu,Yin Liu,Hualing Liu,Hui Liu,Jianwen Liu,Xuebo Liu,Changyong Liu,Wei Liu,Hong Liu,Hong Luan,Suxin Luo,Caidong Luo,Kalan Luo,Yingchao Luo,Genshan Ma,Shixin Ma,Shuren Ma,Yi-Tong Ma,Shaolin Mao,Xiaochuan Ma,Xiaowen Ma,Wei Wang,Lijun Meng,Fanju Meng,Shaoping Nie,Yanbo Niu,Zhihong Ou,Zewei Ouyang,Daoquan Peng,Xuemei Peng,Xiaowei Peng,Xiaoyong Qi,Peng Qu,Shuqiu Qu,Gengsheng Sang,Yuhuan Shi,Zhiyuan Song,Jin Su,Xi Su,Zhenqi Su,Qinfeng Su,Yidan Su,Yuemin Sun,Xiaofei Sun,Yingxian Sun,Fakuan Tang,Jiong Tang,Lilong Tang,Xingsheng Tang,Xin Tang,Guizhou Tao,Ling Tao,Tao Jian-hong,Miao Tian,Wei Tuo,Tian Tuo,Changqian Wang,Honhju Wang,Huifeng Wang,Jingfeng Wang,Zhirong Wang,Ningfu Wang,Wei Wang,Yan Wang,Yanggan Wang,Bin Wang,Siding Wang,Xiaojun Wang,Wang Lin,Chuntong Wang,Yanli Wang,Qichun Wang,Zhongshan Wang,Jinru Wei,Wei Lin,Wei Li,Di Wu,Lirong Wu,Chunyang Wu,Keng Wu,Qiang Wu,Tong-guo Wu,Jiabin Xi,Shudong Xia,Jun Xiao,Ping Xie,Qiang Xie,Shuanli Xin,G. Xin,Bo Xu,Xu Dawen,Gang Xu,Weiting Xu,Zesheng Xu,Jing Xu,Jinchuan Yan,Junru Chen,Zhijian Yang,Zhiming Yang,Bosong Yang,Tianlun Yang,Xiangjun Yang,Yanzong Yang,JiaoMei Yang,Jian Yang,Yuheng Yang,Jie Yang,Xiaoli Yang,Liqiong Yang,Jianfeng Ye,Shaowu Ye,Jinxing Yi,Jiyan Yin,Bo Yu,Yang Yu,Zuyi Yuan,Zheng Zhang,Chunyan Zhang,Guixia Zhang,Hong Zhang,Man Zhang,Peiying Zhang,Ping Zhang,Yonglin Zhang,Xianan Zhang,Huifang Zhang,Xiaoqin Zhang,Peng Zhang,Congliang Zhang,Shu‐Hua Zhang,Tao Zhang,Xianxian Zhao,Xingsheng Zhao,Yulan Zhao,Fang Zhao,Jingshan Zhao,Ruiping Zhao,Zheng Yang,Zeqi Zheng,Yanlie Zheng,Qiaoqing Zhong,Yuhua Zhu,Dongmei Zhu
出处
期刊:JAMA Cardiology [American Medical Association]
卷期号:7 (5): 484-484 被引量:14
标识
DOI:10.1001/jamacardio.2022.0117
摘要

Despite advances in the treatment of ST-segment elevation myocardial infarction (STEMI), little is known about how this evolving knowledge is applied in current clinical practice in China.To evaluate hospital performance and temporal trends in the management of STEMI.This study used data from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project, a nationwide quality improvement registry, in collaboration with the American Heart Association and the Chinese Society of Cardiology. Participants included patients with STEMI admitted to 143 tertiary hospitals across China from November 2014 to July 2019, and data were analyzed from November 2020 to December 2021.Levels, hospital-level variations, and trends for utilization rates of the 9 management strategies with Class I recommendations in Chinese and US guidelines.A total of 57 560 hospitalizations with STEMI were included. Overall, 20.0% of patients received all the care according to the 9 guideline-recommended strategies. The performance rate of quality measures was low for reperfusion therapy (61.0%, 35 115/57 560 patients), β-blocker at discharge (68.3%, 37 750/55 285 patients), angiotensin-converting enzyme inhibitor or angiotensin receptor blocker at discharge (55.1%, 2524/4578 patients), and smoking cessation counseling (36.5%, 9586/26 265 patients) among those who were eligible. Of 25 563 patients who underwent primary percutaneous coronary intervention (PCI), 66.8% underwent this procedure within 90 minutes of hospital arrival. Of 1128 patients who underwent fibrinolysis therapy, 253 (22.4%) underwent this treatment within 30 minutes of hospital arrival. Measures with high performance rates included receipt of dual antiplatelet therapy within 24 hours (95.5%, 54 263/56 848 patients) and at discharge (91.8%, 51 452/56 019 patients) and receipt of statin at discharge (93.0%, 52 214/56 141 patients) for those eligible. There was significant variation between hospitals in all-or-none score (ranging from 0 to 61.9%) and performance of individual measures. The quality of care improved during the study period, especially for reperfusion therapy, primary PCI within the first 90 minutes of hospital arrival, and smoking cessation counseling.The quality of care for patients hospitalized with STEMI does not meet guideline-recommended strategies in China, with only 1 in 5 patients receiving all the care according to the 9 guideline-recommended strategies. Large disparities in the quality of care exist across hospitals.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
Lucas应助蓝天采纳,获得10
刚刚
suen完成签到,获得积分10
1秒前
科研通AI2S应助guard采纳,获得10
2秒前
2秒前
3秒前
彭哒哒发布了新的文献求助10
4秒前
赵川发布了新的文献求助10
4秒前
4秒前
you完成签到 ,获得积分10
5秒前
6秒前
橙子fy16_发布了新的文献求助10
6秒前
8秒前
念之完成签到 ,获得积分10
8秒前
8秒前
旭旭完成签到 ,获得积分10
9秒前
9秒前
SiO2完成签到 ,获得积分10
9秒前
qingqing168发布了新的文献求助10
10秒前
10秒前
於芷波发布了新的文献求助10
11秒前
11秒前
11秒前
每天都要哈哈哈完成签到,获得积分20
11秒前
千城暮雪发布了新的文献求助10
12秒前
Luckovo完成签到 ,获得积分10
14秒前
顾矜应助Two-Capitals采纳,获得10
14秒前
14秒前
14秒前
lyy66964193完成签到,获得积分10
15秒前
15秒前
科研通AI2S应助橙子fy16_采纳,获得10
18秒前
小蘑菇应助linjinhualu采纳,获得10
18秒前
小美酱发布了新的文献求助10
19秒前
guard发布了新的文献求助10
19秒前
21秒前
samjoo发布了新的文献求助10
21秒前
shjyang完成签到,获得积分0
24秒前
24秒前
高分求助中
The ACS Guide to Scholarly Communication 2500
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
PraxisRatgeber Mantiden., faszinierende Lauerjäger. – Buch gebraucht kaufen 700
Mantiden - Faszinierende Lauerjäger – Buch gebraucht kaufen 700
Acute Care Physical Therapy 500
Ожившие листья и блуждающие цветы. Практическое руководство по содержанию богомолов [Alive leaves and wandering flowers. A practical guide for keeping praying mantises] 500
Development of a new synthetic process for the synthesis of (S)-methadone and (S)- and (R)-isomethadone as NMDA receptor antagonists for the treatment of depression 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3095061
求助须知:如何正确求助?哪些是违规求助? 2747028
关于积分的说明 7592325
捐赠科研通 2398494
什么是DOI,文献DOI怎么找? 1272568
科研通“疑难数据库(出版商)”最低求助积分说明 615390
版权声明 598906